Physician profile
David Avila
NPI 1598916090
$568.84
in general payments reported to CMS, 2019-2025
10 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $15.19 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $291.28 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $69.61 | 2025 | Caplyta |
| Inari Medical, INC. | $47.06 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $42.87 | 2025 | Optowire, Savvywire |
| Neurocrine Biosciences, INC. | $26.36 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $21.22 | 2025 | Abilify Asimtufii |
| Vanda Pharmaceuticals INC. | $21.01 | 2025 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $19.72 | 2025 | Austedo Xr |
| Bard Peripheral Vascular, INC. | $15.19 | 2024 | Denali Vena Cava Filter |
| Janssen Pharmaceuticals, INC | $14.52 | 2025 | Invega Sustenna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Avila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.